Medical News

RSS

24-year long asthma study is answering doctors' questions about asthma and its causes

Doctors have concluded that children do not usually outgrow asthma after puberty as was previously assumed. There are also other factors that contribute to the onset of asthma in test subjects, including infection and obesity.

5 Aug 2004

Mefloquine, an anti-malarial drug plays a critical role in movement, vision and memory

Brown University researchers have discovered that mefloquine, an anti-malarial drug, blocks two gap junction proteins, or connexins, in low doses and with very few side effects in the brains of laboratory mice.

5 Aug 2004

2,000 alcohol-fuelled troublemakers were handed fixed penalty notices

Nearly 2,000 alcohol-fuelled troublemakers were handed fixed penalty notices in the first four weeks of this summer's police enforcement campaign.

5 Aug 2004

25% of young men tested positive for a sexually transmitted infection (STI)

25% of young men attending a new community sexual health clinic, run by Guy’s and St Thomas’ NHS Foundation Trust in the heart of Brixton, have tested positive for a sexually transmitted infection (STI).

5 Aug 2004

Humans can speed up their own evolution

A study by J. Todd Streelman, new assistant professor of biology at the Georgia Institute of Technology suggests that humans may have sped up the evolutionary clock for one species of fish.

5 Aug 2004

Current estimates have cardiovascular disease (CVD) accounting for 17 million deaths annually

Renowned public health specialist, Professor Stephen Leeder, will present the central findings of a report highlighting the disturbing trend towards a growth in cardiovascular disease in developing countries, at a special colloquium to be held at The University of Sydney.

5 Aug 2004

Approval of fixed-dose combination treatments for HIV-1 infection

The Food and Drug Administration has announced the approvals of Epzicom (abacavir/lamivudine) and Truvada (tenofovir disoproxil/emtricitabine), two fixed-dose combination treatments for HIV-1 infection.

5 Aug 2004

Approval of an injectable filler to correct facial fat loss in people with HIV/AIDS

The Food and Drug Administration has approved an injectable filler to correct facial fat loss in people with human immunodeficiency virus (HIV) infection.

5 Aug 2004

Experimental vaccine against ricin

Scientists have developed an experimental vaccine against ricin, a potential biological threat agent, which fully protected mice from aerosol challenge with lethal doses of the toxin.

5 Aug 2004

Exclusively breastfeeding for the first six months provides all the energy and nutrients a child needs

Exclusively breastfeeding infants for the first six months of their lives provides all the energy and nutrients a child needs while reducing the risks of infant diarrheal and respiratory infections, according to the Pan American Health Organization (PAHO).

5 Aug 2004

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

A new clinical study to determine how people with rheumatoid arthritis (RA) evaluate improvements in disease symptoms will be carried out by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the Department of Health and Human Services' National Institutes of Health.

5 Aug 2004

Overactive brain circuit brings on depression

A brain imaging study by the NIH's National Institute of Mental Health (NIMH) has found that an emotion-regulating brain circuit is overactive in people prone to depression – even when they are not depressed.

5 Aug 2004

E-Text equipment assists visually-impaired students

With numerous book bindings scattered on the floor, the room looked as if there had been a rebellion against literature. But in fact, students were celebrating the new equipment added to Eastern Michigan University’s Center for Adaptive Technology and Education (CATE), that currently serves enrolled students, faculty and staff with a disability.

5 Aug 2004

Approval of cholesterol-lowering therapy Lipitor for the prevention of cardiovascular disease

Pfizer has announced that the U.S. Food and Drug Administration has approved its cholesterol-lowering therapy Lipitor® (atorvastatin calcium) for the prevention of cardiovascular disease by reducing heart attack risk in people with normal to mildly elevated cholesterol levels who have other cardiovascular risk factors.

5 Aug 2004

Protein loss plays role in acute T-cell leukemia

The loss of a key protein (Smad3) in a pathway that helps prevent tumors from forming is specific to one form of childhood leukemia, but not to other pediatric and adult forms of leukemia, according to a new study published in the August 5, 2004, New England Journal of Medicine.

5 Aug 2004

Medical News

24-year long asthma study is answering doctors' questions about asthma and its causes

Mefloquine, an anti-malarial drug plays a critical role in movement, vision and memory

2,000 alcohol-fuelled troublemakers were handed fixed penalty notices

25% of young men tested positive for a sexually transmitted infection (STI)

Humans can speed up their own evolution

Current estimates have cardiovascular disease (CVD) accounting for 17 million deaths annually

Approval of fixed-dose combination treatments for HIV-1 infection

Approval of an injectable filler to correct facial fat loss in people with HIV/AIDS

Experimental vaccine against ricin

Exclusively breastfeeding for the first six months provides all the energy and nutrients a child needs

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

Overactive brain circuit brings on depression

E-Text equipment assists visually-impaired students

Approval of cholesterol-lowering therapy Lipitor for the prevention of cardiovascular disease

Protein loss plays role in acute T-cell leukemia

New screening test for oesophageal (food pipe) cancer

Bristol-Myers Squibb final settlement with Securities and Exchange Commission (SEC)

New neck pain study

17.6 million American adults (8.5 percent) meet standard diagnostic criteria for an alcohol use disorder

Moderate exercise helps beat fatigue from prostate radiation

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News